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about the role of  ABCB11 and ABCC2 polymorphisms 
in both intrahepatic cholestasis of  pregnancy (ICP) 
and contraceptive-induced cholestasis[1]. The authors 
observed an association between the ABCB11 1331T > 
C polymorphism and the above mentioned cholestatic 
disorders. Additionally, the authors claimed of  a lack 
of  association with 3 single nucleotide polymorphisms 
(SNPs) in ABCC2 gene, concluding that common ABCC2 
polymorphisms are not associated with the development 
of  ICP. 
We would like to make several comments on these 
findings, particularly concerning to the lack of  association 
with ABCC2 gene variants. First of  all, a note of  caution 
should be added to the reported findings, as the markers 
assumed by the authors as common variants (rs2273697, 
rs17222723 and rs8187710), except for rs2273697, include 
one allele at a very low frequency, as the rs17222723-A allele 
frequency is 0.067 and the rs8187710-A allele frequency 
is 0.059, at least for data from the HapMap project for 
Caucasians and from a rough estimation of  own author’s 
data[1]. Consequently, in the group of  patients included 
by the authors only 5 out 33 patients showed either the 
rs172227234 or rs8187710 heterozygous AT or AG 
genotype, respectively, and none of  them showed the 
homozygous AA genotype. The same happened in the 
pregnant control group. Thus, in this frame, the statistical 
power of  the study even taking into account the additive 
genetic model is very low (less than 20%) owing to the lower 
MAF of  these variants.
Second, we wish to note that we recently published[2] a 
candidate gene association study showing the contribution 
of  six ABCC2 gene variants to the risk of  ICP. The 
study involved promoter, coding and non-coding regions 
of  ABCC2 (4 tag SNPs representing 46 polymorphic 
sites located in 70 kb of  the gene, in addition to the 
rs17222723 and rs8187710), and showed that, at least, one 
of  the ABCC2 variants (rs3740066) at the exon 28 was 
significantly associated with ICP being the estimated risk 
of  disease for homozygous AA subjects 4-fold higher in 
comparison with homozygous GG subjects (OR, 4.44; 
95% CI, 1.83-10.78; P < 0.001). Although more studies 
are necessary to establish whether rs3740066 is the causal 
variant or one linked to it, our results suggest that ICP 
may be associated with common variants of  ABCC2. 
Interestingly, we also included in the analysis rs172227234 
and rs8187710, and we did not observe significant 
differences in genotype frequencies of  the 2 SNPs in ICP 
and controls. 
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Abstract
The pathogenesis of intrahepatic cholestasis of pregnancy 
(ICP), a disorder that adversely affects maternal wellbeing 
and fetal outcome, is unclear. However, multiple factors 
probably interact along with a genetic predisposition. We 
would like to add some comments on a paper recently 
published concerning the role of ABCB11 and ABCC2 
polymorphisms in both ICP and contraceptive-induced 
cholestasis, especially in the light of our recently published 
findings about a positive association between ICP and 
ABCC2 common variants. 
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To The ediTor
We read with great interest the article of  Meier et al. 
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In conclusion, we consider that the pathogenic 
involvement of  ABCC2 (MRP2) in ICP is still an open issue, 
particularly in the frame of  a small number of  studies about 
the role of  the ABCC2 gene variants in cholestatic disorders, 
with the exception of  the Dubin Johnson phenotype. 
Although the major physiological function of  ABCC2 
is to transport conjugated metabolites into the bile 
canaliculus, previous data demonstrated that a major 
metabolite of  human estrogen metabolism, estradiol-
17-β-D-glucuronide (E217βG), has been shown to be 
transported by both MRP2 and MRP3[3]. These findings 
support that ABCC2 represents an alternative candidate 
protein involved in the pathogenesis of  hormonal 
cholestasis. Additionally, it was shown that MRP2 is 
regulated by three distinct nuclear receptor signaling 
pathways that converge on a common response element in 
the 5'-flanking region of  this gene[4]. Hence, the intimate 
mechanism, by which gene variants including ABCC2 may 
influence ICP susceptibility, is not fully explored and a 
complex network involving nuclear receptors and other 
transcription factors may be the cause of  liver injury in 
cholestatic disorders[5].
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